MAPT and Alzheimer disease: Core 1 biomarkers, such as α-amyloid Aβ42, phosphorylated tau (pTau 181), (p-tau217), (p-tau231), and amyloid PET, determine the early AD phage that is detectable in vivo and can identify the presence of AD in both symptomatic and asymptomatic individuals [10].